Subscribe

M1 Kliniken AG (M12.DE)

EUR18.10 -0.28 (-1.52%)
DE XETRA Healthcare Medical - Care Facilities
Address Grünauer Strasse 5 12557
Berlin, DE
CEO Attila Strauss
Website m1-kliniken.de
IPO 2015-09-14
ISIN DE000A0STSQ8

Explore sections of this company profile

Also trades on Deutsche Börse · M12.DE (EUR) Other OTC · MKLNF (USD)
Description

M1 Kliniken AG, a Berlin, Germany-based entity established in 2007 and operating as a subsidiary of MPH Health Care AG, manages medical facilities dedicated to aesthetic and plastic surgery across Germany, Austria, the Netherlands, Switzerland, the United Kingdom, Croatia, and Australia. The company's operations are segmented into two core divisions: Beauty and Trade. The Beauty segment is responsible for the creation and commercialization of pharmaceutical, medical, and medical technology products tailored for aesthetic medicine and cosmetic dermatology. Meanwhile, the Trade segment engages in the distribution of pharmaceuticals, biosimilars, and other medical products and devices, serving critical therapeutic areas such as oncology, HIV, rheumatology, neurology, cardiovascular conditions, and narcotics. Products are supplied to healthcare professionals, pharmacies, and wholesale distributors under the "M1 Select" brand. M1 Kliniken AG's operational footprint encompasses a network of outpatient specialist centers, a specialized surgical clinic center, and 46 distinct specialist locations branded as "M1 Med Beauty." Additionally, the company is involved in the acquisition, administration, and divestiture of real estate, predominantly within the healthcare industry.

Market Cap & Enterprise Value
Merger & Acquisition History

No mergers or acquisitions recorded for this company.

Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary Loading…
Indicator 1D1W2W3W1M
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
Averages
Trend
Price
Levels
Draw
EUR18.10 -0.28 (-1.52%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
5.9K
Beta
1.07
Float Shares
5.80M
Free Float %
30.9%
Price Performance
1D5D1M3M6M YTD1Y3Y5Y10YMax
+0.00% +0.00% +9.20% +10.21% +5.20% +4.63% +40.74% +136.91% +85.37% +169.50% +280.00%
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
vs.
Loading histogram data…

Revenue flow

Revenue by geography

Revenue by segment

From To

Revenue composition

From To

By product

By geography

Financial Statements

Income Statement

Balance Sheet

Cash Flow Statement

Key Metrics

Financial Ratios

Employees

Financial Growth (CAGR)

Market Data

Price Targets & DCF
Current price
18.10
DCF (Unlevered) 39.33 +117.3%
DCF (Levered) 51.01 +181.8%

DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.

Ratings Trend (MoM) 100% Bullish
Rating 2026-04 Change
Strong Buy 1 0
Buy 0 -1
Hold 0 0
Sell 0 0
Strong Sell 0 0
Quality scores
Altman Z-Score
11.11
Safe zone
Piotroski F-Score
8 / 9
Strong
MOAT Score
4 / 10
Developing
Composite Rating
A
Overall Score
4 / 5
High
DCF Score
5 / 5
High
ROE Score
5 / 5
High
ROA Score
5 / 5
High
D/E Score
3 / 5
Medium
P/E Score
2 / 5
Medium
P/Book Score
2 / 5
Medium
Operational MOAT
✗ Below peers
  • ✓
    Revenue growth Medical - Care Facilities: +10.2%
    +7.4% Q4'25: +9.2% (vs Q4'23)
  • ✓
    EPS growth Medical - Care Facilities: +19.2%
    +38.4% ★ Q4'25: +50.0% (vs Q4'23)
  • ✓
    FCF margin FCF growth · Medical - Care Facilities: +32.0%
    +9.8% ★ Q4'25: +8.2% (vs Q4'23)
  • ✗
    EBIT margin Medical - Care Facilities: +11.3%
    +9.8% Q4'25: +9.2% (vs Q4'23)
  • ✓
    ROIC Medical - Care Facilities: +6.8%
    +21.3% ★ Q4'25: +37.8% (vs Q4'23)
  • ✓
    Share dilution Medical - Care Facilities: +0.0%
    +0.0% Q4'25: +1.8% (vs Q4'23)
  • ✓
    Debt / EBITDA Net debt/EBITDA · Medical - Care Facilities: 0.99×
    0.25× ★ Q4'25: 0.14× (vs Q4'23)
Valuation Multiples From To
Price Forecast (3Y) From To
Model
Adjust
P/E
Theoretical Return — If Invested Today

* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.

DCF Interactive Model (UFCF)
Projection years:
Market assumptions
▶ WACC components (optional)
Ke (Cost of Equity) = Rf + β (1.04) × ERP
WACC = 97% × Ke + 3% × Kd (15.0%) × (1−t)

Modifying these values recalculates WACC automatically.

Business assumptions
—
Intrinsic value (base): 39.33 Current price: 18.10
Enterprise Value: — Equity Value: — Terminal Value: — TV as % of EV: —

Base values reflect the latest available data for this company and market conditions.

Consensus Estimates
Metric Dec 2016
actual 		Dec 2017
actual 		Dec 2018
actual 		Dec 2019
actual 		Dec 2020
actual 		Dec 2021
actual 		Dec 2022
actual 		Dec 2023
actual 		Dec 2024
actual 		Dec 2025
actual 		Dec 2026
1 Rev. Ana.
1 EPS Ana. 		Dec 2027
1 Rev. Ana.
1 EPS Ana. 		Dec 2028
1 Rev. Ana.
Revenue
35.96M
est: 37.02M (-2.9%)
47.19M
est: 44.76M (+5.4%)
65.21M
est: 62.77M (+3.9%)
77.22M
est: 80.83M (-4.5%)
159.59M
est: 177.93M (-10.3%)
314.61M
est: 318.73M (-1.3%)
285.29M
est: 283.64M (+0.6%)
316.32M
est: 333.27M (-5.1%)
339.18M
est: 341.08M (-0.6%)
364.30M
est: 355.00M (+2.6%)
371.00M
371.00M – 371.00M
+4.5% YoY
377.00M
377.00M – 377.00M
+1.6% YoY
475.45M
475.45M – 475.45M
+26.1% YoY
EBITDA
5.79M
est: 2.61M (+121.4%)
7.82M
est: 8.24M (-5.1%)
8.81M
est: 12.88M (-31.6%)
11.21M
est: 12.88M (-13.0%)
10.59M
est: 38.58M (-72.6%)
19.78M
est: 63.79M (-69.0%)
16.07M
est: 65.05M (-75.3%)
21.79M
est: 58.66M (-62.8%)
33.44M
est: 60.03M (-44.3%)
40.49M
est: 62.48M (-35.2%)
65.30M
65.30M – 65.30M
+4.5% YoY
66.36M
66.36M – 66.36M
+1.6% YoY
83.68M
83.68M – 83.68M
+26.1% YoY
EBIT
5.50M
est: 1.88M (+192.0%)
7.36M
est: 5.21M (+41.2%)
8.10M
est: 7.77M (+4.3%)
7.81M
est: 7.97M (-2.0%)
6.10M
est: 14.62M (-58.3%)
14.13M
est: 24.18M (-41.5%)
10.21M
est: 24.66M (-58.6%)
16.48M
est: 56.27M (-70.7%)
28.23M
est: 57.68M (-51.1%)
35.60M
est: 59.94M (-40.6%)
62.64M
62.64M – 62.64M
+4.5% YoY
63.65M
63.65M – 63.65M
+1.6% YoY
80.28M
80.28M – 80.28M
+26.1% YoY
Net Income
5.01M
est: 5.75M (-12.9%)
5.78M
est: 5.98M (-3.4%)
6.61M
est: 7.85M (-15.8%)
9.73M
est: 8.16M (+19.2%)
6.82M
est: 17.89M (-61.9%)
8.91M
est: 29.58M (-69.9%)
4.32M
est: 6.36M (-32.1%)
10.27M
est: 16.88M (-39.1%)
16.02M
est: 17.74M (-9.7%)
22.13M
est: 18.00M (+23.0%)
20.23M
20.23M – 20.23M
+12.4% YoY
21.71M
21.71M – 21.71M
+7.3% YoY
—
— – —
-100.0% YoY
SGA
4.99M
est: 1.06M (+370.8%)
1.90M
est: 4.54M (-58.2%)
2.47M
est: 9.74M (-74.7%)
5.84M
est: 16.84M (-65.3%)
6.21M
est: 33.34M (-81.4%)
9.11M
est: 55.11M (-83.5%)
8.99M
est: 56.20M (-84.0%)
7.05M
est: 8.16M (-13.6%)
7.28M
est: 8.36M (-12.9%)
6.63M
est: 8.69M (-23.7%)
9.08M
9.08M – 9.08M
+4.5% YoY
9.23M
9.23M – 9.23M
+1.6% YoY
11.64M
11.64M – 11.64M
+26.1% YoY
EPS
0.33
est: 0.31 (+6.5%)
0.38
est: 0.41 (-7.3%)
0.39
est: 0.38 (+3.6%)
0.56
est: 0.40 (+39.9%)
0.37
est: 0.28 (+31.0%)
0.48
est: 0.40 (+19.8%)
0.24
est: 0.31 (-21.5%)
0.54
est: 0.91 (-40.7%)
0.86
est: 0.87 (-1.4%)
1.19
est: 0.97 (+22.7%)
1.09
1.09 – 1.09
+12.4% YoY
1.17
1.17 – 1.17
+7.3% YoY
—
— – —
-100.0% YoY
Historical Ratings (3M)
Date Rating Overall DCF ROE ROA D/E P/E P/B
2026-05-29 A 4/5 5/5 5/5 5/5 3/5 2/5 2/5
2026-05-28 A 4/5 5/5 5/5 5/5 3/5 2/5 2/5
2026-05-27 A 4/5 5/5 5/5 5/5 3/5 2/5 2/5
2026-05-26 A 4/5 5/5 5/5 5/5 3/5 2/5 2/5
2026-05-25 A 4/5 5/5 5/5 5/5 3/5 2/5 2/5
2026-05-22 A- 4/5 5/5 4/5 5/5 2/5 2/5 3/5
2026-05-21 A- 4/5 5/5 4/5 5/5 2/5 2/5 3/5
2026-05-20 A- 4/5 5/5 4/5 5/5 2/5 2/5 3/5
2026-05-19 A- 4/5 5/5 4/5 5/5 2/5 2/5 3/5
2026-05-18 A- 4/5 5/5 4/5 5/5 2/5 2/5 3/5
2026-05-15 A 4/5 5/5 4/5 5/5 2/5 3/5 3/5
2026-05-14 A 4/5 5/5 4/5 5/5 2/5 3/5 3/5
2026-05-13 A 4/5 5/5 4/5 5/5 2/5 3/5 3/5
2026-05-12 A 4/5 5/5 4/5 5/5 2/5 3/5 3/5
2026-05-11 A 4/5 5/5 4/5 5/5 2/5 3/5 3/5
2026-05-08 A 4/5 5/5 4/5 5/5 2/5 3/5 3/5
2026-05-07 A 4/5 5/5 4/5 5/5 2/5 3/5 3/5
2026-05-06 A 4/5 5/5 4/5 5/5 2/5 3/5 3/5
2026-05-05 A 4/5 5/5 4/5 5/5 2/5 3/5 3/5
2026-05-04 A 4/5 5/5 4/5 5/5 2/5 3/5 3/5
2026-04-30 A 4/5 5/5 4/5 5/5 2/5 3/5 3/5
2026-04-29 A 4/5 5/5 4/5 5/5 2/5 3/5 3/5
2026-04-28 A 4/5 5/5 4/5 5/5 2/5 3/5 3/5
2026-04-27 A 4/5 5/5 4/5 5/5 2/5 3/5 3/5
2026-04-24 A 4/5 5/5 4/5 5/5 2/5 3/5 3/5
2026-04-23 A 4/5 5/5 4/5 5/5 2/5 3/5 3/5
2026-04-22 A 4/5 5/5 4/5 5/5 2/5 3/5 3/5
2026-04-21 A- 4/5 5/5 4/5 5/5 1/5 3/5 3/5
2026-04-20 A- 4/5 5/5 4/5 5/5 1/5 3/5 3/5
2026-04-17 A- 4/5 5/5 4/5 5/5 1/5 3/5 3/5
2026-04-16 A- 4/5 5/5 4/5 5/5 1/5 3/5 3/5

Owner Earnings

Owner's Earnings (history) From To
Owner alignment
Owner's Earnings TTM
69.63M
OE per share TTM
3.74
Owner's Yield
19.75%
Maintenance CapEx ratio
7.45%
Maint CapEx / Avg PPE
5.4%

Ownership Overview

Ownership breakdown

Ownership breakdown not available.

At a glance
Institutional holders
—
Total invested
—
Insider transactions (90d)
0
Beneficial owners (>5%)
0
Beneficial owners (>5%)

No beneficial ownership filings recorded.

Institutional Activity (13F)

Institutional ownership trend

Institutional history not available.

Top institutional holders

Top holders not available.

ETF Ownership

Top ETFs holding this stock

This company is not held by any ETF in our universe.

Insider Activity

Insider Activity — Latest Quarter

No insider activity available.

Insider buys vs sells (history)

Insider history not available.

Recent insider transactions

No recent insider transactions.

Executive team

Top executives
EBIT / Employee
162.6K
Shares Outstanding
18.78M

Executive compensation

Executive compensation (annual)

Executive compensation not available.

CEO compensation breakdown

No CEO compensation history available.

Proxy statements

Proxy statements (DEF 14A)

No proxy statements available for this company yet.

Recent SEC filings

Recent SEC filings

No SEC filings available for this company yet.

Executive team

NameTitleCompensationGender
Attila Strauss Member of Management Board & Chief Executive Officer — male
Katharina Zimmnau CFO & Member of Executive Board — female
ESG Score History

No data available for this company.

Senate Trading Activity

No Senate trading activity found for this company.

House Trading Activity

No House trading activity found for this company.

Market share among peers
Peer comparison — filtered group (TTM)
Your opinion

Share your view on this stock and instantly see how the community has voted over the last 6 months.

These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.

Dividend yield history

Dividend history

Earnings history

Earnings reports

Stock splits

Related companies

Largest companies in Medical - Care Facilities